The genetics of the opioid system and specific drug addictions
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Addiction to drugs is a chronic, relapsing brain disease that has major medical, social, and economic complications. It has been established that genetic factors contribute to the vulnerability to develop drug addiction and to the effectiveness of its treatment. Identification of these factors may increase our understanding of the disorders, help in the development of new treatments and advance personalized medicine. In this review, we will describe the genetics of the major genes of the opioid system (opioid receptors and their endogenous ligands) in connection to addiction to opioids, cocaine, alcohol and methamphetamines. Particular emphasis is given to association and functional studies of specific variants. We will provide information on the sample populations and the size of each study, as well as a list of the variants implicated in association with addiction-related phenotypes, and with the effectiveness of pharmacotherapy for addiction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stress dysregulation of drug reward pathways, and the transition to drug dependence
Koob, & Kreek, M. J. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.05030503 · Cited by 868 · cited 2×
“In contrast, opiate dependents find it aversive, since HPA axis activation is a characteristic of opioid withdrawal (e.g., Bond et al. 1998; Culpepper-Morgan and Kreek 1997; Koob and Kreek 2007; O'Malley et al. 2002).”
BackgroundSelf-citationDrug dependence: stress and dysregulation of brain reward pathways
Kreek, M. J., & Koob, G. F. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00064-7 · Cited by 696 · cited 1×
“Disruption of stress pathways is considered to be one of the causes of addictive disorders (Koob and Kreek 2007; Kreek and Koob 1998).”
BackgroundSelf-citationOslin, D. W., Berrettini, W., Kranzler, H. R., Pettinati, H., Gelernter, J., Volpicelli, J. R., & O'Brien, C. P. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300219 · Cited by 571 · cited 1×
“This prediction has been supported by several studies showing that AD subjects with the 118G allele have better clinical response (Anton et al. 2008; Oroszi et al. 2009; Oslin et al. 2003; Ray and Hutchison 2007).”
ResultAllelic Expression Imbalance of Human mu Opioid Receptor (OPRM1) Caused by Variant A118G
Zhang, Y., Wang, D., Johnson, A. D., Papp, A. C., & Sadée, W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504942200 · Cited by 563 · cited 1×
“…et al. (2006) rs2236857 Intron 1 EA Levran et al. (2008, 2009), Zhang et al. (2008), Xuei et al. (2007) ), reduced mRNA levels in vivo and in vitro (Zhang et al. 2005), altered signal transduction (PKA and pERK), in vitro (Deb et al. 2010), and enhanced affinity for beta-endorphin (Bond et al.…”
BackgroundThe dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors
Bruchas, M. R., Land, B. B., & Chavkin, C. (2010) · Brain Research · doi:10.1016/j.brainres.2009.08.062 · Cited by 544 · cited 1×
“…wide variety of physiological systems, including pain regulation, addiction to drugs of abuse, neuroendocrine regulation, cardiovascular function, respiration, temperature regulation , feeding behavior, and stress responsivity (e.g., Bruchas et al. 2010; Knoll and Carlezon 2010; Kreek et al. 2005).”
BackgroundDynorphin, stress, and depression
Knoll, A. T., & Carlezon, W. A. (2010) · Brain Research · doi:10.1016/j.brainres.2009.09.074 · Cited by 465
Anton, R. F., Oroszi, G., O’Malley, S., Couper, D., Swift, R., Pettinati, H., & Goldman, D. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.2.135 · Cited by 451 · cited 1×
“This prediction has been supported by several studies showing that AD subjects with the 118G allele have better clinical response (Anton et al. 2008; Oroszi et al. 2009; Oslin et al. 2003; Ray and Hutchison 2007).”
ResultPharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments
Kreek, M. J., Bart, G., Lilly, C., Laforge, K. S., & Nielsen, D. A. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.1 · Cited by 391 · cited 3×
“…wide variety of physiological systems, including pain regulation, addiction to drugs of abuse, neuroendocrine regulation, cardiovascular function, respiration, temperature regulation , feeding behavior, and stress responsivity (e.g., Bruchas et al. 2010; Knoll and Carlezon 2010; Kreek et al. 2005).”
BackgroundSelf-citationRay, L. A., & Hutchison, K. E. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.9.1069 · Cited by 258 · cited 1×
“This prediction has been supported by several studies showing that AD subjects with the 118G allele have better clinical response (Anton et al. 2008; Oroszi et al. 2009; Oslin et al. 2003; Ray and Hutchison 2007).”
ResultMedical safety and side effects of methadone in tolerant individuals
Kreek, M. J. (1973) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1973.03220060039009 · Cited by 247 · cited 1×
“Long-term MMT normalizes HPA axis activity in heroin addicts (Kreek 1973, 1983).”
BackgroundSelf-citationKroslak, T., LaForge, K. S., Gianotti, R. J., Ho, A., Nielsen, D. A., & Kreek, M. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04738.x · Cited by 213
Self-citationLiability to substance use disorders: 1. Common mechanisms and manifestations
Vanyukov, M. M., Tarter, R. E., Kirisci, L., Kirillova, G. P., Maher, B. S., & Clark, D. B. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.08.002 · Cited by 205 · cited 1×
“Several studies use the more general phenotypes that are based on the concept of common drug use disorders (DUD) liability (Vanyukov et al. 2003), including substance dependence (SD), substance use disorder (SUD), and illicit drug dependence.”
BackgroundNaltrexone for the Treatment of Amphetamine Dependence: A Randomized, Placebo-Controlled Trial
Jayaram-Lindström, N., Hammarberg, A., Beck, O., & Franck, J. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08020304 · Cited by 185 · cited 1×
“NTX also modulates amphetamine-induced effects and has a potential in the treatment of amphetamine dependence (Jayaram-Lindstrom et al. 2008a, b).”
BackgroundSequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin
Shi, J., Hui, L., Xu, Y., Wang, F., Huang, W., & Hu, G. (2002) · Human Mutation · doi:10.1002/humu.9026 · Cited by 140 · cited 2×
“…As 64 74 H (Nomura et al. 2006) As 143 209 H (Racz et al. 2008) E 247 247 H (Sander et al. 1998) E 327 340 H (Schinka et al. 2002) EA 179 297 H (Shi et al. 2002) As 145 48 H (Smith et al. 2005) AA 76 71 H EA 94 57 H (Szeto et al. 2001) As 200 97 H (Town et al. 1999) EA 105 122 H (Wei et al.…”
ResultYuferov, V., Fussell, D., LaForge, K. S., Nielsen, D. A., Gordon, D., Ho, A., Leal, S. M., Ott, J., & Kreek, M. J. (2004) · Pharmacogenetics · doi:10.1097/00008571-200412000-00002 · Cited by 128
Self-citationTroisi, A., Frazzetto, G., Carola, V., Di Lorenzo, G., Coviello, M., D'Amato, F. R., Moles, A., Siracusano, A., & Gross, C. (2011) · Social Neuroscience · doi:10.1080/17470919.2010.482786 · Cited by 118 · cited 1×
“…association in the specific population indicated in the specific addiction column The SNP 118A[G was also associated with social hedonic capacity (Troisi et al. 2011) and with MAP psychosis , having latency less than 3 years from first methamphetamine intake in Japanese subjects (Ide et al.…”
BackgroundBarr, C. S., Schwandt, M., Lindell, S. G., Chen, S. A., Goldman, D., Suomi, S. J., Higley, J. D., & Heilig, M. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.369 · Cited by 105 · cited 1×
“…altered stress reactivity, reduced cortisol response to maternal separation in infancy and to acute alcohol exposure later in life and attenuated cortisol levels during the maternal postpartum period (Barr et al. 2007, 2010; Miller et al. 2004; Schwandt et al. 2011; Vallender et al. 2010).”
BackgroundKreek, M. J., Wardlaw, S. L., Hartman, N., Raghunath, J., Friedman, J., Schneider, B., & Frantz, A. G. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90529-5 · Cited by 92
Self-citationHuman kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction
Gerra, G., Leonardi, C., Cortese, E., D'Amore, A., Lucchini, A., Strepparola, G., Serio, G., Farina, G., Magnelli, F., Zaimovic, A., et al. (2007) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30510 · Cited by 90 · cited 2×
“A study of an Italian sample replicated this finding (Gerra et al. 2007).”
BackgroundCulpepper-Morgan, J. A., & Kreek, M. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90289-4 · Cited by 54
Self-citationKakko, J., von Wachenfeldt, J., Svanborg, K. D., Lidström, J., Barr, C. S., & Heilig, M. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.001 · Cited by 41 · cited 2×
“No association studies of the opioid system genes have been reported on the response to buprenorphine treatment (see below a study of the HPA axis reactivity after buprenorphine-maintained patients (Kakko et al. 2008).”
BackgroundExpression of pronociceptin and its receptor is downregulated in the brain of human alcoholics
Kuzmin, A., Bazov, I., Sheedy, D., Garrick, T., Harper, C., & Bakalkin, G. (2009) · Brain Research · doi:10.1016/j.brainres.2009.05.067 · Cited by 40
Extensive Changes in the Expression of the Opioid Genes between Humans and Chimpanzees
Cruz-Gordillo, P., Fedrigo, O., Wray, G. A., & Babbitt, C. C. (2010) · Brain, Behavior and Evolution · doi:10.1159/000320968 · Cited by 16
Cited by
Strang, J., Volkow, N. D., Degenhardt, L., Hickman, M., Johnson, K., Koob, G. F., Marshall, B. D. L., Tyndall, M., & Walsh, S. L. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0137-5 · Cited by 639
Sex differences in neural mechanisms mediating reward and addiction
Becker, J. B., & Chartoff, E. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0125-6 · Cited by 459
Opioid receptors: drivers to addiction?
Darcq, E., & Kieffer, B. L. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0028-x · Cited by 352
Opiate addiction and cocaine addiction: underlying molecular neurobiology and genetics
Kreek, M. J., Levran, O., Reed, B., Schlussman, S. D., Zhou, Y., & Butelman, E. R. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60390 · Cited by 220
“Polymorphisms in several genes, including genes encoding opioid receptors and ligands, were indicated in association with drug addiction (82–84).”
Self-citationSobczak, M., Sałaga, M., Storr, M. A., & Fichna, J. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-013-0753-x · Cited by 203
Metadata
- Authors
- Levran, O., Yuferov, V., & Kreek, M. J.
- Venue
- Human Genetics
- Published
- 2012-05-01
- Volume
- 131
- Issue
- 6
- Pages
- 823-842
- ISSN
- 0018-7348 (ISSN-L)
- 0340-6717
- 1432-1203
- OpenAlex
- W1986653661
- Cited by
- 143
- References
- 23
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.